Compare HTH & PRGO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | HTH | PRGO |
|---|---|---|
| Founded | 1998 | 1887 |
| Country | United States | Ireland |
| Employees | N/A | N/A |
| Industry | Major Banks | Biotechnology: Pharmaceutical Preparations |
| Sector | Finance | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 2.2B | 2.0B |
| IPO Year | 2004 | 1991 |
| Metric | HTH | PRGO |
|---|---|---|
| Price | $39.19 | $14.52 |
| Analyst Decision | Hold | Buy |
| Analyst Count | 2 | 3 |
| Target Price | ★ $37.50 | $20.33 |
| AVG Volume (30 Days) | 443.0K | ★ 2.2M |
| Earning Date | 01-29-2026 | 02-26-2026 |
| Dividend Yield | 2.02% | ★ 8.06% |
| EPS Growth | ★ 51.72 | N/A |
| EPS | ★ 2.64 | N/A |
| Revenue | $1,274,536,000.00 | ★ $4,281,800,000.00 |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | $3.22 | N/A |
| P/E Ratio | $15.03 | ★ N/A |
| Revenue Growth | ★ 7.30 | N/A |
| 52 Week Low | $27.35 | $12.17 |
| 52 Week High | $40.41 | $30.93 |
| Indicator | HTH | PRGO |
|---|---|---|
| Relative Strength Index (RSI) | 69.71 | 51.28 |
| Support Level | $35.32 | $14.13 |
| Resistance Level | $40.41 | $14.69 |
| Average True Range (ATR) | 0.98 | 0.49 |
| MACD | 0.21 | -0.01 |
| Stochastic Oscillator | 78.19 | 57.86 |
Hilltop Holdings Inc is a Dallas-based financial holding company. The Company has two primary business units, PCC (banking and mortgage origination) and Securities Holdings (broker-dealer). The banking segment includes the operations of the Bank. The banking segment provides business and consumer banking services from offices located throughout Texas and generates revenue from its portfolio of earning assets. The broker-dealer segment includes the operations of Securities Holdings, which operates through its wholly owned subsidiaries Hilltop Securities, Asset Managment LLC, etc. The broker-dealer segment generates a majority of its revenues from fees and commissions earned from investment advisory and securities brokerage services. Majority of revenue is from Banking Segment.
Perrigo is one of the largest consumer health companies in the world. Since 2018, Perrigo divested its animal health and generic pharmaceuticals businesses to solely focus on consumer self-care. In North America (two thirds of total sales), the firm's product mix is anchored in private-label consumer health goods, which are sold to major retailers like Walmart, Amazon, Costco, and CVS. Perrigo also plays in Europe, Australia, and parts of Asia where it primarily generates revenue through its national brands, including Compeed, Solpadeine, Coldrex, and ellaOne.